J. Craig Rowlands

Incorporating New Technologies Into Toxicity Testing and Risk Assessment: Moving From 21st Century Vision to a Data-Driven Framework

Russell S. Thomas, Martin A. Philbert, Scott S. Auerbach et al. · Toxicological Sciences · 2013 · 268 citations · Full text

Physiologically-based Pharmacokinetic Modeling, Environmental Health, 21St Century Vision +22

Trans-activation by the human aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator proteins: direct interactions with basal transcription factors.

J. Craig Rowlands, Iain J. McEwan, Jan-Ακε Gustafsson · Molecular Pharmacology · 1996 · 110 citations

Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes

Grace Patlewicz, Ted W. Simon, J. Craig Rowlands et al. · Regulatory Toxicology and Pharmacology · 2015 · 103 citations · Full text

Riskbenefit Ratio, Regulatory Safety Science, Preventive Medicine +23

Knockout of the aryl hydrocarbon receptor results in distinct hepatic and renal phenotypes in rats and mice

Joshua Harrill, Renee Hukkanen, Marie Lawson et al. · Toxicology and Applied Pharmacology · 2013 · 81 citations

Molecular Pharmacology, Hepatology, Biochemistry +10

Cross-species Comparisons of Transcriptomic Alterations in Human and Rat Primary Hepatocytes Exposed to 2,3,7,8-Tetrachlorodibenzo-p-dioxin

Michael B. Black, Robert A. Budinsky, Alan A. Dombkowski et al. · Toxicological Sciences · 2012 · 72 citations

Rat Primary Hepatocytes, Gene Expression Changes, Transcriptomic Alterations +24